Panel rejects U.S.-style registry for acne drug

From the Globe and Mail:
There is no need for Canada to follow the U.S. lead and create a registry of patients taking an anti-acne drug that causes severe birth defects, an expert advisory panel has told Health Canada.

In its question-and-answer report posted on Health Canada's website this week, the 10-member panel said it "unanimously rejected" the notion of a U.S.-style registry, which requires enrolment by thousands of American patients taking isotretinoin, the doctors who prescribe the drug and the pharmacists who dispense it. ...more